Is dosage reduction appropriate in patients who respond well to anti-TNF-alpha agents?

被引：4

作者：

Berthelot, JM ^{[1
]}

Varin, S ^{[1
]}

机构：

[1] CHU Nantes, Hotel Dieu, Dept Rheumatol, F-44093 Nantes 01, France

来源：

JOINT BONE SPINE | 2004年 / 71卷 / 04期

关键词：

anti-TNF alpha; infliximab; etanercept; adalimumab; cost; dosage;

D O I：

10.1016/j.jbspin.2004.01.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：257 / 260

页数：4

共 23 条

[1]

Awni WM, 2003, ARTHRITIS RHEUM, V48, pS140

[2] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].

Bathon, JM ;

Martin, RW ;

Fleischmann, RM ;

Tesser, JR ;

Schiff, MH ;

Keystone, EC ;

Genovese, MC ;

Wasko, MC ;

Moreland, LW ;

Weaver, AL ;

Markenson, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593

[3]

Brocq O, 2002, PRESSE MED, V31, P1836

[4] The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis - Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial [J].

Clair, EWS ;

Wagner, CL ;

Fasanmade, AA ;

Wang, B ;

Schaible, T ;

Kavanaugh, A ;

Keystone, EC .

ARTHRITIS AND RHEUMATISM, 2002, 46 (06) :1451-1459

[5] Dose reduction of etanercept - can we treat more patients using a fixed budget? [J].

Clunie, G ;

Voules, S ;

Watts, R .

RHEUMATOLOGY, 2003, 42 (04) :600-601

[6]

den Broeder A, 2002, J RHEUMATOL, V29, P2288

[7] Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-α [J].

den Broeder, AA ;

Creemers, MCW ;

van Gestel, AM ;

van Riel, PLCM .

RHEUMATOLOGY, 2002, 41 (06) :638-642

[8]

Felson DT, 1998, ARTHRITIS RHEUM, V41, P1564, DOI 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO

[9]

2-M

[10] Unwillingness of rheumatoid arthritis patients to risk adverse effects [J].

Fraenkel, L ;

Bogardus, S ;

Concato, J ;

Felson, D .

RHEUMATOLOGY, 2002, 41 (03) :253-261

← 1 2 3 →